| |
| | Klearsen Corporation |
 | | Klearsen has proposed a development program to be conducted in phases intended to 1) validate the efficacy of the therapy, 2) optimize the materials or coatings, delivery fields, and the treatment protocols, 3) cost reduce and miniaturize the implantable electronics where applicable, and 4) produce selected products suitable for clinical trials. |
 | | Utilizing these techniques, the specific surfaces to be energized, the time that they are energized, the depth of penetration, and the rate at which the ions are perfused into the surrounding tissue can all be precisely controlled to provide effective antiseptic treatment for diverse clinical requirements. |
 | | This technology may be readily applied for treatment of infections of the skin, for wound care, and for the antiseptic maintenance of long term indwelling medical devices. |
| www.stratnet2000.com /klearsen/DermaSepticTechnology.html (2307 words) |
|